文献速递胸部肿瘤乳腺癌泌尿男性生殖肿瘤

2023年癌症统计

Cancer statistics, 2023.
PubMed 文献 · CA Cancer J Clin · 2023-01-01

美国癌症协会估算2023年美国新发癌症1,958,310例、癌症死亡609,820例。前列腺癌发病率2014至2019年每年增加3%,而女性肺癌下降速度仅为男性的一半(1.1% vs 2.6%)。

要点

  • 2023年美国预计新发癌症1,958,310例,癌症死亡609,820例。
  • 2014至2019年前列腺癌发病率每年增加3%,相当于额外增加99,000例新发病例。

核心结论

  • 癌症死亡率继续下降,但乳腺癌、前列腺癌和子宫体癌发病率上升可能减弱未来进展,且这些癌症的死亡率种族差异最大。

研究设计与样本

  • 美国癌症协会每年基于中央癌症登记处的发病率数据和国家卫生统计中心的死亡率数据,估算美国新发癌症病例和死亡数,并汇总基于人群的癌症发生与结局数据。

主要发现

  • 2023年美国预计发生1,958,310例新发癌症和609,820例癌症死亡。
  • 前列腺癌发病率在经历20年下降后,2014至2019年每年增加3%,相当于额外增加99,000例新发病例。
  • 2015至2019年女性肺癌发病率每年下降1.1%,男性每年下降2.6%。
  • 2012至2019年,首批接种人乳头瘤病毒疫苗的20岁出头女性宫颈癌发病率下降65%。

关键数值与推荐

  • 2016至2020年白血病、黑色素瘤和肾癌死亡率每年下降约2%,尽管发病率稳定或上升。
  • 2015至2019年女性肺癌发病率下降速度(每年1.1%)为男性(每年2.6%)的一半。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes using incidence data collected by central cancer registries and mortality data collected by the National Center for Health Statistics. In 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Cancer incidence increased for prostate cancer by 3% annually from 2014 through 2019 after two decades of decline, translating to an additional 99,000 new cases; otherwise, however, incidence trends were more favorable in men compared to women. For example, lung cancer in women decreased at one half the pace of men (1.1% vs. 2.6% annually) from 2015 through 2019, and breast and uterine corpus cancers continued to increase, as did liver cancer and melanoma, both of which stabilized in men aged 50 years and older and declined in younger men. However, a 65% drop in cervical cancer incidence during 2012 through 2019 among women in their early 20s, the first cohort to receive the human papillomavirus vaccine, foreshadows steep reductions in the burden of human papillomavirus-associated cancers, the majority of which occur in women. Despite the pandemic, and in contrast with other leading causes of death, the cancer death rate continued to decline from 2019 to 2020 (by 1.5%), contributing to a 33% overall reduction since 1991 and an estimated 3.8 million deaths averted. This progress increasingly reflects advances in treatment, which are particularly evident in the rapid declines in mortality (approximately 2% annually during 2016 through 2020) for leukemia, melanoma, and kidney cancer, despite stable/increasing incidence, and accelerated declines for lung cancer. In summary, although cancer mortality rates continue to decline, future progress may be attenuated by rising incidence for breast, prostate, and uterine corpus cancers, which also happen to have the largest racial disparities in mortality.

来源:CA Cancer J Clin,查看原文。版权归原作者所有。

引用

  1. Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023. PMID: 36633525. doi:10.3322/caac.21763

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。